Prevention of Fatal Clostridium difficile-Associated Disease during Continuous Administration of Clindamycin in Hamsters

Journal of Infectious Diseases

Volumn 188, Issue 12, 2003, Pages 1922-1927

  Merrigan, Michelle M ^a,b,d   Sambol, Susan P ^a,b   Johnson, Stuart ^c,d   Gerding, Dale N ^a,b,c,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c HINES VA HOSPITAL   (United States)

^d LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL SPORE; BACTERIAL STRAIN; BIOSAFETY; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; DISEASE ASSOCIATION; FATALITY; HAMSTER; INFECTION PREVENTION; MINIMUM INHIBITORY CONCENTRATION; MOUTH; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; STOMACH; TOXICITY;

EID: 0347950950     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/379836     Document Type: Article

References (19)

1. Gerding DN, Olson MM, Peterson LR, et al. Clostridium difficile-associated diarrhea and colitis in adults: a prospective case-controlled epidemiologic study. Arch Intern Med 1986; 146:95-100.
2. Siegel DL, Edelstein PH, Nachamkin I. Inappropriate testing for diarrheal diseases in the hospital. JAMA 1990; 263:979-82.
3. Yannelli B, Gurevich I, Schoch PE, Cunha BA. Yield of stool cultures, ova and parasite tests, and Clostridium difficile determinations in nosocomial diarrhea. Am J Infect Control 1988; 16:246-9.
4. Bignardi GE. Risk factors for Clostridium difficile infection. J Hosp Infect 1998; 40:1-15.
5. Johnson S, Samore M, Farrow K, et al. Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. N Engl J Med 1999; 341:1645-51.
6. Sambol SP, Tang JK, Merrigan MM, Johnson S, Gerding D. Infection of hamsters with epidemiologically important strains of Clostridium difficile. J Infect Dis 2001; 183:1760-6.
7. Sambol S, Merrigan M, Lyerly D, Gerding D, Johnson S. Toxin gene analysis of a variant strain of Clostridium difficile that causes human clinical disease. Infect Immun 2000; 68:5480-7.
8. Dallal RM, Harbrecht BG, Boujoukas AJ, et al. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg 2002; 235:363-72.
9. Miller MA, Hyland M, Ofner-Agostini M, Gourdeau M, Ishak M. Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals. Infect Control Hosp Epidemiol 2002; 23:137-40.
10. Kyne L, Hamel MB, Polavaram R, Kelly CP. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002; 34:346-53.
11. Shim J, Johnson S, Samore M, Bliss D, Gerding DN. Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet 1998; 351:633-6.
12. Kyne L, Warny M, Qamar A, Kelly C. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 2000; 342:390-7.
13. Sambol S, Merrigan M, Tang JK, Johnson S, Gerding DN. Colonization for the prevention of Clostridium difficile disease in hamsters. J Infect Dis 2002; 186:1781-9.
14. Farrow KA, Lyras D, Rood JI. The macrolide-lincosamide-streptogramin B resistance determinant from Clostridium difficile 630 contains two erm (B) genes. Antimicrob Agents Chemother 2000; 44:411-3.
15. Farrow KA, Lyras D, Rood JI. Genomic analysis of the erythromycin resistance element Tn5398 from Clostridium difficile. Microbiology 2001; 147: 2717-28.
16. Spigaglia P, Mastrantonio P. Analysis of the macrolide-lincosamide- streptogramin B (MLS(B)) determinant in strains of Clostridium difficile. Microb Drug Resist 2002; 8:45-53.
17. Clabots CR, Johnson S, Bettin K, et al. Development of a rapid and efficient restriction endonuclease analysis typing system for Clostridium difficile and correlation with other typing systems. J Clin Microbiol 1993; 31:1870-5.
18. Johnson S, Clabots CR, Linn FV, Olson MM, Peterson LR, Gerding DN. Nosocomial Clostridium difficile colonization and disease. Lancet 1990; 336: 97-100.
19. Bliss DZ, Johnson S, Clabots C, Savik K, Gerding DN. Comparison of cycloserine-cefoxitin-fructose agar (CCFA) and taurocholate-CCFA for recovery of Clostridium difficile during surveillance of hospitalized patients. Diagn Microbiol Infect Dis 1997; 29:1-4.